22.73  -0.203 (-0.88%)		10-07 15:58
Open: 22.76 High: 22.975 Volume: 1,996		Pre. Close: 22.9328 Low: 22.55 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	27.44	1-year :	28.45
Resists	First :	23.5	Second :	24.36
Pivot price	23.61
Supports	First :	22.11	Second :	18.39
MAs	MA(5) :	23.43	MA(20) :	23.27
	MA(100) :	20.79	MA(250) :	18.68
MACD	MACD :	0.2	Signal :	0.3
%K %D	K(14,3) :	47.4	D(3) :	63.9
RSI	RSI(14): 45.6
52-week	High :	24.36	Low :	15

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ WDNA ] has closed above bottom band by 3.3%. Bollinger Bands are 22.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	23.02 - 23.15	23.15 - 23.29
Low:	22.18 - 22.33	22.33 - 22.49
Close:	22.45 - 22.71	22.71 - 22.98

This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected returns, and other key characteristics. The benchmark index itself is crafted to invest in global, exchange-listed companies that are poised for significant transformation through breakthroughs in genetic research and biotechnology. It's important to note that this fund is categorized as non-diversified.

Tue, 06 Oct 2026
Precision Trading with Wisdomtree Biorevolution Fund (WDNA) Risk Zones - Stock Traders Daily

Sat, 26 Sep 2026
Responsive Playbooks and the WDNA Inflection - Stock Traders Daily

Sun, 06 Sep 2026
Avoiding Lag: Real-Time Signals in (WDNA) Movement - Stock Traders Daily

Wed, 12 Aug 2026
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool

Wed, 05 Aug 2026
The BioRevolution Has Accelerated - Seeking Alpha

Tue, 12 Nov 2024
WDNA ETF Price and Chart — CBOE:WDNA - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: CBOE
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.